Camargo Taps PhDs, Postdoctoral Researchers for Training - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Camargo Taps PhDs, Postdoctoral Researchers for Training

Source: Applied Clinical Trials

Camargo Pharmaceutical Services, which specializes in 505(b)(2) approval pathway drug development, has tapped academic organizations close to its Raleigh, NC site in a unique internship program. According to Duke University's postdoctoral services office, which is one university partnering with Camargo on this program, historically, PhD students and postdoctoral researchers were training for tenured faculty positions, but now only 20% of graduates with a PhD will go on to tenured academic appointments. With the decrease in academic appointments, more graduates with a PhD are looking for positions beyond academia and that includes positions in pharmaceutical research.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here